Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Apyx Medical (APYX) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $9.1 million.

  • Apyx Medical's Operating Expenses fell 1378.79% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.5 million, marking a year-over-year decrease of 2236.63%. This contributed to the annual value of $48.2 million for FY2024, which is 1024.95% down from last year.
  • Per Apyx Medical's latest filing, its Operating Expenses stood at $9.1 million for Q3 2025, which was down 1378.79% from $9.7 million recorded in Q2 2025.
  • Over the past 5 years, Apyx Medical's Operating Expenses peaked at $14.7 million during Q4 2023, and registered a low of $8.7 million during Q1 2025.
  • Its 5-year average for Operating Expenses is $12.1 million, with a median of $12.6 million in 2024.
  • In the last 5 years, Apyx Medical's Operating Expenses skyrocketed by 4192.13% in 2021 and then crashed by 3062.72% in 2025.
  • Quarter analysis of 5 years shows Apyx Medical's Operating Expenses stood at $13.8 million in 2021, then grew by 2.39% to $14.2 million in 2022, then rose by 3.75% to $14.7 million in 2023, then fell by 18.31% to $12.0 million in 2024, then fell by 24.0% to $9.1 million in 2025.
  • Its last three reported values are $9.1 million in Q3 2025, $9.7 million for Q2 2025, and $8.7 million during Q1 2025.